A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients

NCT00000824 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Lymphocytes, Activated

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)